SPC314
Avatrombopag og lyfjafræðilega viðeigandi sölt þess, sérstaklega avatrombopag maleat
Status:
VeittApplication date:
17.9.2020Application published:
15.10.2020Grant published:
15.7.2023
Max expiry date:
23.6.2034Medicine name:
DopteletMedicine for children:
No
Timeline
Today
17.9.2020Application
15.10.2020Publication
15.7.2023Registration
23.6.2034Expires
Marketing license
IS authorization number:
EU/1/19/1373/001-002Date:
28.6.2019
Foreign authorization number:
EU/1/19/1373Date:
20.6.2019
Owner
Name:
Astellas Pharma Inc.Address:
3-11, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 103-8411 JP
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3246325